North America CD28 Market: Rising Demand for Immune-Based Solutions

adicionou um novo artigo Outro

2026-09-16 09:46:52 - Traduzir -

The North America CD28 market is expanding due to strong investment in immuno-oncology, autoimmune disease research, and advanced biopharmaceutical development. The region benefits from established research infrastructure and increasing development of CD28-targeted antibodies, fusion proteins, and other immune-modulating approaches. North America was identified as the largest regional market...

0 Comentários 0 Compartilhamentos 30 Visualizações 0 Anterior